Comparison of the properties of human breast cancer cells: MCF-7 and MCF-7 cells selected for resistance to etoposide.
Cory
A H
AH
Department of Biochemistry, Brody School of Medicine, East Carolina University, Greenville, NC 27858-4354, USA.
Cory
J G
JG
D000970:Antineoplastic Agents / Q000494:pharmacology; D000972:Antineoplastic Agents, Phytogenic / Q000494:pharmacology*; D002851:Chromatography, High Pressure Liquid; D003609:Dactinomycin / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004317:Doxorubicin / Q000494:pharmacology; D019008:Drug Resistance, Neoplasm; D005047:Etoposide / Q000494:pharmacology*; D005434:Flow Cytometry; D006801:Humans; D020024:Leukotriene Antagonists / Q000494:pharmacology; D011422:Propionates / Q000494:pharmacology; D011500:Protein Synthesis Inhibitors / Q000494:pharmacology; D011804:Quinolines / Q000494:pharmacology; D014407:Tumor Cells, Cultured; D014665:Vasodilator Agents / Q000494:pharmacology; D014700:Verapamil / Q000494:pharmacology; D014747:Vinblastine / Q000494:pharmacology
D000970:Antineoplastic Agents; D000972:Antineoplastic Agents, Phytogenic; D020024:Leukotriene Antagonists; D011422:Propionates; D011500:Protein Synthesis Inhibitors; D011804:Quinolines; D014665:Vasodilator Agents; D003609:Dactinomycin; C059141:verlukast; D014747:Vinblastine; D005047:Etoposide; D004317:Doxorubicin; D014700:Verapamil